We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HLLY:NYSEHolley Inc. Analysis

Data as of 2026-04-08 - not real-time

$2.92

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Holley Inc. (HLLY) is trading at $2.92, well below its 20‑day ($3.02), 50‑day ($3.62) and 200‑day ($3.39) simple moving averages, indicating a technical discount that aligns with a RSI of 37 and a bullish MACD histogram (+0.04). The stock sits on a support level around $2.70 and faces resistance near $3.37, while volume has been trending down, suggesting limited short‑term buying pressure but also a potential for a bounce if fundamentals hold. On the fundamentals side, the company delivered a 10.9% YoY revenue growth to $613.5 M and improved net income to $6.3 M, yet earnings per share missed consensus ($0.04 vs $0.09), creating a mixed earnings narrative. Valuation metrics are attractive – a trailing PE of 18.3, a forward PE under 7, a price‑to‑book of 0.77 and a price‑to‑sales of 0.57 – pointing to a significant upside potential reflected in the 76.9% upside/downside estimate. However, the balance sheet is strained, with a debt‑to‑equity ratio above 124 and net debt far exceeding cash, which dampens profitability (ROE 4.4%) and raises liquidity concerns. The recent acquisition of HRX expands Holley's safety and racing apparel line, potentially diversifying revenue streams and supporting the growth narrative in a high‑volatility, high‑beta (1.43) consumer‑cyclical sector.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Price near technical support with bullish MACD histogram
  • Revenue beat and 10.9% YoY sales growth
  • Earnings miss creates short‑term price pressure

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Acquisition of HRX broadens product portfolio
  • Forward PE under 7 suggests strong valuation upside
  • Consistent revenue growth despite cyclical environment

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio limits financial flexibility
  • Cyclical consumer‑cyclical sector exposure
  • Brand strength and diversification potential from recent acquisitions

Key Metrics & Analysis

Financial Health

Revenue Growth11.00%
Profit Margin3.13%
P/E Ratio18.3
ROE4.41%
ROA4.65%
Debt/Equity124.89
P/B Ratio0.8
Op. Cash Flow$46.2M
Free Cash Flow$9.6M

Technical Analysis

TrendNeutral
RSI37.4
Support$2.70
Resistance$3.37
MA 20$3.02
MA 50$3.62
MA 200$3.39
MACDBullish
VolumeDecreasing
Fear & Greed Index84.96

Valuation

Target Price$5.17
Upside/Downside76.94%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.19
Volatility66.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.